Vanguard Group Inc Fulcrum Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,071,143 shares of FULC stock, worth $9.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,071,143
Previous 2,538,665
20.97%
Holding current value
$9.86 Million
Previous $24 Million
20.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FULC
# of Institutions
138Shares Held
59.3MCall Options Held
4.33MPut Options Held
309K-
Ra Capital Management, L.P. Boston, MA11.6MShares$37.3 Million1.08% of portfolio
-
Rtw Investments, LP New York, NY5.85MShares$18.8 Million0.61% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$15.4 Million0.0% of portfolio
-
Cowen And Company, LLC2.96MShares$9.51 Million0.47% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.54MShares$8.16 Million0.66% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $167M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...